|
US2003199A
(en)
|
1930-05-31 |
1935-05-28 |
Johnson Frank James |
Automatic coal stoker
|
|
US2003149A
(en)
|
1931-05-22 |
1935-05-28 |
Autographic Register Co |
Manifolding
|
|
US2003065A
(en)
|
1931-06-20 |
1935-05-28 |
John R Ditmars |
Composition for coating sheets, fibrous stocks, and the like
|
|
US2004102A
(en)
|
1932-02-24 |
1935-06-11 |
Daniel A Dickey |
Hollow steel propeller construction
|
|
US2004138A
(en)
|
1932-11-30 |
1935-06-11 |
Byers A M Co |
Method of making wrought iron pipe
|
|
US2002165A
(en)
|
1933-07-08 |
1935-05-21 |
Charles A Winslow |
Air cleaner
|
|
US2003187A
(en)
|
1933-10-02 |
1935-05-28 |
Frederick H Shaw |
Automobile radio device
|
|
US2003166A
(en)
|
1933-10-26 |
1935-05-28 |
Zancan Ottavio |
Front drive for motor cars
|
|
US2001051A
(en)
|
1933-12-01 |
1935-05-14 |
Angelina Mariani |
Tamperproof meter box with cutout control and fuse drawer for electric meters
|
|
US2004092A
(en)
|
1933-12-15 |
1935-06-11 |
John L Chaney |
Device for indicating the temperature of liquids
|
|
US2003060A
(en)
|
1934-04-02 |
1935-05-28 |
Ernest L Heckert |
Thermostatic controlling device
|
|
US2667486A
(en)
|
1951-05-24 |
1954-01-26 |
Research Corp |
2,4-diamino pteridine and derivatives
|
|
IE38778B1
(en)
|
1973-02-02 |
1978-05-24 |
Ciba Geigy |
New 1,2,4-benzotriazine derivatives
|
|
AU535258B2
(en)
|
1979-08-31 |
1984-03-08 |
Ici Australia Limited |
Benzotriazines
|
|
DE3205638A1
(de)
|
1982-02-17 |
1983-08-25 |
Hoechst Ag, 6230 Frankfurt |
Trisubstituierte pyrimidin-5-carbonsaeuren und deren derivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
|
|
US4490289A
(en)
|
1982-09-16 |
1984-12-25 |
Hoffmann-La Roche Inc. |
Homogeneous human interleukin 2
|
|
US5624925A
(en)
|
1986-09-25 |
1997-04-29 |
Sri International |
1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
|
|
JP2598100B2
(ja)
|
1988-08-31 |
1997-04-09 |
キヤノン株式会社 |
電子写真感光体
|
|
US5214059A
(en)
|
1989-07-03 |
1993-05-25 |
Hoechst-Roussel Pharmaceuticals Incorporated |
2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders
|
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
|
US5776502A
(en)
|
1989-07-18 |
1998-07-07 |
Oncogene Science, Inc. |
Methods of transcriptionally modulating gene expression
|
|
US5041430A
(en)
*
|
1989-09-18 |
1991-08-20 |
Du Pont Mereck Pharmaceutical Company |
Oral anticoagulant/platelet inhibitor low dose formulation
|
|
JPH03127790A
(ja)
|
1989-10-11 |
1991-05-30 |
Morishita Pharmaceut Co Ltd |
Ｎ―（１ｈ―テトラゾール―５―イル）―２―アニリノ―５―ピリミジンカルボキシアミド類及びその合成中間体
|
|
GB9003553D0
(en)
|
1990-02-16 |
1990-04-11 |
Ici Plc |
Herbicidal compositions
|
|
JP2839106B2
(ja)
|
1990-02-19 |
1998-12-16 |
キヤノン株式会社 |
電子写真感光体
|
|
GB9012592D0
(en)
|
1990-06-06 |
1990-07-25 |
Smithkline Beecham Intercredit |
Compounds
|
|
FR2665159B1
(fr)
|
1990-07-24 |
1992-11-13 |
Rhone Poulenc Sante |
Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
|
IE74711B1
(en)
|
1990-07-27 |
1997-07-30 |
Ici Plc |
Fungicides
|
|
GB9016800D0
(en)
|
1990-07-31 |
1990-09-12 |
Shell Int Research |
Tetrahydropyrimidine derivatives
|
|
DE4025891A1
(de)
|
1990-08-16 |
1992-02-20 |
Bayer Ag |
Pyrimidyl-substituierte acrylsaeureester
|
|
JPH05345780A
(ja)
|
1991-12-24 |
1993-12-27 |
Kumiai Chem Ind Co Ltd |
ピリミジンまたはトリアジン誘導体及び除草剤
|
|
HUT63941A
(en)
|
1992-05-15 |
1993-11-29 |
Hoechst Ag |
Process for producing 4-alkyl-substituted pyrimidine-5-carboxanilide derivatives, and fungicidal compositions comprising same
|
|
US5438130A
(en)
|
1993-01-15 |
1995-08-01 |
Cambridge Neuroscience, Inc. |
Fucosylated guanosine disulfates as excitatory amino acid antagonists
|
|
JPH0741461A
(ja)
|
1993-05-27 |
1995-02-10 |
Eisai Co Ltd |
スルホン酸エステル誘導体
|
|
JPH0782183A
(ja)
|
1993-09-09 |
1995-03-28 |
Canon Inc |
液晶中間体化合物、液晶性化合物、高分子液晶化合物、高分子液晶共重合体化合物、それらの組成物、液晶素子および記録装置
|
|
DE4338704A1
(de)
|
1993-11-12 |
1995-05-18 |
Hoechst Ag |
Stabilisierte Oligonucleotide und deren Verwendung
|
|
US5530000A
(en)
|
1993-12-22 |
1996-06-25 |
Ortho Pharmaceutical Corporation |
Substituted pyrimidinylaminothiazole derivatives useful as platelet aggreggation inhibitors
|
|
GB9506466D0
(en)
|
1994-08-26 |
1995-05-17 |
Prolifix Ltd |
Cell cycle regulated repressor and dna element
|
|
US5597826A
(en)
|
1994-09-14 |
1997-01-28 |
Pfizer Inc. |
Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
|
|
DE19502912A1
(de)
|
1995-01-31 |
1996-08-01 |
Hoechst Ag |
G-Cap Stabilisierte Oligonucleotide
|
|
US6326487B1
(en)
|
1995-06-05 |
2001-12-04 |
Aventis Pharma Deutschland Gmbh |
3 modified oligonucleotide derivatives
|
|
EP0850228A1
(en)
|
1995-09-01 |
1998-07-01 |
Signal Pharmaceuticals, Inc. |
Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
TR199801255T2
(xx)
|
1995-12-29 |
1998-10-21 |
Smithkline Beecham Corporation |
Vitronektin resept�r antagonistleri.
|
|
JPH09274290A
(ja)
|
1996-02-07 |
1997-10-21 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料用の現像液および処理方法
|
|
CA2246753C
(en)
|
1996-02-23 |
2005-05-10 |
Eli Lilly And Company |
Non-peptidyl vasopressin v1a antagonists
|
|
DE59707681D1
(de)
|
1996-10-28 |
2002-08-14 |
Rolic Ag Zug |
Vernetzbare, photoaktive Silanderivate
|
|
KR100503701B1
(ko)
|
1996-11-20 |
2005-07-26 |
인트로겐 테라페티스, 인코퍼레이티드 |
아데노바이러스 벡터를 생산하고 정제하는 개선된 방법
|
|
JP3734903B2
(ja)
|
1996-11-21 |
2006-01-11 |
富士写真フイルム株式会社 |
現像処理方法
|
|
JPH10153838A
(ja)
|
1996-11-22 |
1998-06-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JP3720931B2
(ja)
|
1996-11-26 |
2005-11-30 |
富士写真フイルム株式会社 |
ハロゲン化銀写真感光材料の処理方法
|
|
AU729194B2
(en)
|
1996-12-04 |
2001-01-25 |
Research Foundation Of The State University Of New York, The |
Method for making wet strength paper
|
|
US5935383A
(en)
|
1996-12-04 |
1999-08-10 |
Kimberly-Clark Worldwide, Inc. |
Method for improved wet strength paper
|
|
EP0946528B1
(en)
|
1996-12-23 |
2003-04-09 |
Bristol-Myers Squibb Pharma Company |
OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
|
|
JPH10207019A
(ja)
|
1997-01-22 |
1998-08-07 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
|
JPH10213820A
(ja)
|
1997-01-31 |
1998-08-11 |
Canon Inc |
液晶素子及び液晶装置
|
|
DE59807348D1
(de)
|
1997-02-05 |
2003-04-10 |
Rolic Ag Zug |
Photovernetzbare Silanderivate
|
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
JPH10260512A
(ja)
|
1997-03-19 |
1998-09-29 |
Fuji Photo Film Co Ltd |
ハロゲン化銀感光材料の処理方法
|
|
JPH10310583A
(ja)
|
1997-05-09 |
1998-11-24 |
Mitsubishi Chem Corp |
ピリドンアゾ系化合物、感熱転写用色素およびそれを使用した感熱転写材料
|
|
US6070126A
(en)
|
1997-06-13 |
2000-05-30 |
William J. Kokolus |
Immunobiologically-active linear peptides and method of identification
|
|
TW436485B
(en)
|
1997-08-01 |
2001-05-28 |
American Cyanamid Co |
Substituted quinazoline derivatives
|
|
US6635626B1
(en)
|
1997-08-25 |
2003-10-21 |
Bristol-Myers Squibb Co. |
Imidazoquinoxaline protein tyrosine kinase inhibitors
|
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
WO1999031073A1
(en)
|
1997-12-15 |
1999-06-24 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel pyrimidine-5-carboxamide derivatives
|
|
CA2314401A1
(en)
|
1997-12-22 |
1999-07-01 |
Du Pont Pharmaceuticals Company |
Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
|
|
EA200000840A1
(ru)
|
1998-02-17 |
2001-02-26 |
Туларик, Инк. |
Антивирусные производные пиримидина
|
|
ATE232521T1
(de)
|
1998-03-27 |
2003-02-15 |
Janssen Pharmaceutica Nv |
Hiv hemmende pyrimidin derivate
|
|
DE69943247D1
(de)
|
1998-03-27 |
2011-04-14 |
Janssen Pharmaceutica Nv |
HIV hemmende Pyrimidin Derivate
|
|
US6685938B1
(en)
|
1998-05-29 |
2004-02-03 |
The Scripps Research Institute |
Methods and compositions useful for modulation of angiogenesis and vascular permeability using SRC or Yes tyrosine kinases
|
|
DE19830181C1
(de)
|
1998-07-06 |
1999-09-30 |
Inter Control Koehler Hermann |
Mehrpolige elektrische Steckverbindung
|
|
US6136971A
(en)
|
1998-07-17 |
2000-10-24 |
Roche Colorado Corporation |
Preparation of sulfonamides
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
UA72749C2
(en)
|
1998-09-29 |
2005-04-15 |
White Holdings Corp |
Substituted 3-cyanoquinolines, a method for the preparation thereof (variants), pharmaceutical composition based thereon, a method for the treatment, inhibiting the growth or elimination of neoplasms and a method for the treatment, inhibiting progressing or elimination of polycystic kidney disease using them
|
|
US6288082B1
(en)
|
1998-09-29 |
2001-09-11 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
|
US6297258B1
(en)
|
1998-09-29 |
2001-10-02 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
|
CN1144786C
(zh)
|
1998-09-29 |
2004-04-07 |
美国氰胺公司 |
作为蛋白质酪氨酸激酶抑制剂的取代的3-氰基喹啉
|
|
CA2348740A1
(en)
|
1998-12-23 |
2000-07-06 |
Ruth R. Wexler |
Thrombin or factor xa inhibitors
|
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
|
WO2000046203A2
(en)
|
1999-02-04 |
2000-08-10 |
Millennium Pharmaceuticals, Inc. |
G-protein coupled heptahelical receptor binding compounds and methods of use thereof
|
|
CA2366932C
(en)
|
1999-04-15 |
2009-08-25 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
RU2001131356A
(ru)
|
1999-04-21 |
2003-06-27 |
Американ Цианамид Компани (US) |
Замещенные 3-циано-[1.7], [1.5] и [1.8] нафтиридиновые ингибиторы тирозинкиназ
|
|
WO2000071536A1
(en)
|
1999-05-20 |
2000-11-30 |
E.I. Du Pont De Nemours And Company |
Heteroaryloxypyrimidine insecticides and acaricides
|
|
US6710221B1
(en)
|
1999-06-15 |
2004-03-23 |
Kimberly-Clark Worldwide, Inc. |
Absorbent articles incorporating color change graphics
|
|
JP4609691B2
(ja)
|
1999-07-01 |
2011-01-12 |
味の素株式会社 |
複素環化合物及びその医薬用途
|
|
AU6111000A
(en)
|
1999-07-22 |
2001-02-13 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of viral helcase
|
|
HK1046645A1
(zh)
|
1999-07-23 |
2003-01-24 |
盐野义制药株式会社 |
Th2分化抑制剂
|
|
WO2001007401A1
(en)
|
1999-07-23 |
2001-02-01 |
Shionogi & Co., Ltd. |
Tricyclic compounds and drug compositions containing the same
|
|
DE60031127T2
(de)
|
1999-08-12 |
2007-02-01 |
Wyeth Holdings Corp. |
Nsaid und egfr kinase inhibitoren enthaltende pharmazeutische formulierung zur behandlung oder inhibierung von dickdarmpolypen und kolorektalem krebs
|
|
US6093838A
(en)
|
1999-08-16 |
2000-07-25 |
Allergan Sales, Inc. |
Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
US6127382A
(en)
|
1999-08-16 |
2000-10-03 |
Allergan Sales, Inc. |
Amines substituted with a tetrahydroquinolinyl group an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
PL355639A1
(en)
|
1999-09-10 |
2004-05-04 |
Merck & Co, Inc. |
Tyrosine kinase inhibitors
|
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
|
JP2001089412A
(ja)
|
1999-09-22 |
2001-04-03 |
Otsuka Pharmaceut Co Ltd |
ベンゼン誘導体またはその医薬的に許容される塩
|
|
US6506769B2
(en)
|
1999-10-06 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
US7087597B1
(en)
|
1999-10-12 |
2006-08-08 |
Takeda Pharmaceutical Company Limited |
Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof
|
|
WO2001032628A1
(en)
|
1999-11-03 |
2001-05-10 |
Bristol-Myers Squibb Pharma Company |
Cyano compounds as factor xa inhibitors
|
|
GB9929988D0
(en)
|
1999-12-17 |
2000-02-09 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
ES2281372T3
(es)
|
1999-12-29 |
2007-10-01 |
Wyeth |
Inhibidores de proteina-quinasa triciclicos.
|
|
US6638929B2
(en)
|
1999-12-29 |
2003-10-28 |
Wyeth |
Tricyclic protein kinase inhibitors
|
|
US6153752A
(en)
|
2000-01-28 |
2000-11-28 |
Creanova, Inc. |
Process for preparing heterocycles
|
|
EP1294709A2
(en)
|
2000-01-28 |
2003-03-26 |
AstraZeneca AB |
Quinoline derivatives and their use as aurora 2 kinase inhibitors
|
|
US20020165244A1
(en)
|
2000-01-31 |
2002-11-07 |
Yuhong Zhou |
Mucin synthesis inhibitors
|
|
MXPA02007957A
(es)
|
2000-02-17 |
2002-11-29 |
Amgen Inc |
Inhibidores de cinasas.
|
|
ATE329608T1
(de)
|
2000-02-18 |
2006-07-15 |
Yeda Res & Dev |
Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
|
|
ES2240449T3
(es)
|
2000-02-25 |
2005-10-16 |
F. Hoffmann-La Roche Ag |
Moduladores receptores de adenosina.
|
|
WO2001064646A2
(en)
|
2000-03-01 |
2001-09-07 |
Tularik Inc. |
Hydrazones and analogs as cholesterol lowering agents
|
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
EP1261607B1
(en)
|
2000-03-01 |
2008-11-12 |
Janssen Pharmaceutica N.V. |
2,4-disubstituted thiazolyl derivatives
|
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
JP2001247411A
(ja)
|
2000-03-09 |
2001-09-11 |
Tomono Agrica Co Ltd |
有害生物防除剤
|
|
WO2001068186A2
(en)
|
2000-03-13 |
2001-09-20 |
American Cyanamid Company |
Use of cyanoquinolines for treating or inhibiting colonic polyps
|
|
US6613917B1
(en)
|
2000-03-23 |
2003-09-02 |
Allergan, Inc. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
AR028261A1
(es)
|
2000-03-28 |
2003-04-30 |
Wyeth Corp |
Inhibidores triciclicos de la proteina quinasa
|
|
US6608048B2
(en)
|
2000-03-28 |
2003-08-19 |
Wyeth Holdings |
Tricyclic protein kinase inhibitors
|
|
US20030149061A1
(en)
|
2000-04-04 |
2003-08-07 |
Yoshitaka Nishihara |
Oily compositions containing highly fat-soluble drugs
|
|
AU2001244610A1
(en)
|
2000-04-05 |
2001-10-23 |
Shionogi And Co., Ltd. |
Oil-in-water microemulsions containing tricyclic compounds or preconcentrates thereof
|
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
|
DE10024622A1
(de)
|
2000-05-18 |
2001-11-22 |
Piesteritz Stickstoff |
N-(2-Pyrimidinyl)(thio)phosphorsäuretriamide, Verfahren zu ihrer Herstellung und deren Verwendung als Mittel zur Regulierung bzw. Hemmung der enzymatischen Harnstoff-Hydrolyse
|
|
EP1170353B1
(en)
|
2000-07-06 |
2005-11-02 |
Fuji Photo Film Co., Ltd. |
Liquid crystal composition comprising liquid crystal molecules and aligment promoter
|
|
WO2002014319A2
(en)
|
2000-08-11 |
2002-02-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
JP2004509115A
(ja)
|
2000-09-15 |
2004-03-25 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼインヒビターとして有用なピラゾール化合物
|
|
WO2002030358A2
(en)
|
2000-10-11 |
2002-04-18 |
Tularik Inc. |
Modulation of ccr4 function
|
|
AU2002210714A1
(en)
|
2000-11-02 |
2002-06-11 |
Astrazeneca Ab |
Substituted quinolines as antitumor agents
|
|
EP1337513A1
(en)
|
2000-11-02 |
2003-08-27 |
AstraZeneca AB |
4-substituted quinolines as antitumor agents
|
|
US6624180B2
(en)
|
2000-11-20 |
2003-09-23 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
|
|
US20070026433A1
(en)
*
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
|
WO2002053101A2
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications
|
|
WO2002053160A1
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating glaucoma ivb
|
|
JP2002221770A
(ja)
|
2001-01-24 |
2002-08-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料およびその処理方法
|
|
WO2002064096A2
(en)
|
2001-02-16 |
2002-08-22 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
|
ATE324371T1
(de)
|
2001-02-23 |
2006-05-15 |
Merck & Co Inc |
N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten
|
|
AU2002247402A1
(en)
|
2001-03-23 |
2002-10-08 |
Chugai Seiyaku Kabushiki Kaisha |
Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
|
|
EP1389206B1
(en)
|
2001-04-13 |
2006-09-13 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
|
US20040157866A1
(en)
|
2001-04-30 |
2004-08-12 |
Hisashi Takasugi |
Amide compounds
|
|
US7271181B2
(en)
|
2001-05-11 |
2007-09-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
WO2002094766A1
(en)
|
2001-05-18 |
2002-11-28 |
Nihon Nohyaku Co., Ltd. |
Phthalamide derivative, agricultural or horticultural insecticide, and use thereof
|
|
AU2002314252A1
(en)
|
2001-05-28 |
2002-12-09 |
Aventis Pharma S.A. |
Chemical derivatives and the use thereof as an anti-telomerase agent
|
|
WO2002096888A1
(de)
|
2001-05-29 |
2002-12-05 |
Schering Aktiengesellschaft |
Cdk inhibitorische pyrimidine, deren herstellung und verwendung als arzneimittel
|
|
EP1404860B8
(en)
|
2001-05-30 |
2013-12-25 |
The Scripps Research Institute |
Delivery system for nucleic acids
|
|
CA2446756C
(en)
|
2001-06-01 |
2011-03-08 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinase
|
|
DE60214198T2
(de)
|
2001-07-03 |
2007-08-09 |
Vertex Pharmaceuticals Inc., Cambridge |
Isoxazolyl-pyrimidines als inhibitoren von src- und lck-protein-kinasen
|
|
US6861529B2
(en)
|
2001-07-06 |
2005-03-01 |
Pfizer Inc |
Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
|
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
|
CN101851173A
(zh)
|
2001-09-14 |
2010-10-06 |
梅特希尔基因公司 |
组蛋白脱乙酰化酶抑制剂
|
|
WO2003030909A1
(en)
|
2001-09-25 |
2003-04-17 |
Bayer Pharmaceuticals Corporation |
2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
|
|
DE10150614A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Halogen-Metall-Austauschreaktionen
|
|
DE10150610A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Amidbasen
|
|
DE10150615A1
(de)
|
2001-10-12 |
2003-04-30 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte
|
|
WO2003032994A2
(de)
|
2001-10-17 |
2003-04-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
5-substituierte 4-amino-2-phenylamino-pyrimidinderivate und ihre verwendung als beta-amyloid modulatoren
|
|
DK1442019T3
(da)
|
2001-11-01 |
2008-01-14 |
Janssen Pharmaceutica Nv |
Amidderivater som glycogensynthasekinase 3- beta-inhibitorer
|
|
IL161662A0
(en)
|
2001-11-01 |
2004-09-27 |
Janssen Pharmaceutica Nv |
Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors (gsk3 inhibitors)
|
|
PL370137A1
(en)
|
2001-11-27 |
2005-05-16 |
Wyeth Holdings Corporation |
3-cyanoquinolines as inhibitors of egf-r and her2 kinases
|
|
US20050038035A1
(en)
|
2001-11-28 |
2005-02-17 |
Hisashi Takasugi |
Heterocyclic amide compounds as apolipoprotein b inhibitors
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
WO2003057165A2
(en)
|
2002-01-04 |
2003-07-17 |
The Rockefeller University |
COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
|
|
US20030166932A1
(en)
|
2002-01-04 |
2003-09-04 |
Beard Richard L. |
Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
AU2003217323A1
(en)
|
2002-02-05 |
2003-09-02 |
Wyeth |
Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids
|
|
AU2003209077A1
(en)
|
2002-02-08 |
2003-09-02 |
Smithkline Beecham Corporation |
Pyrimidine compounds
|
|
EP1487824B1
(en)
|
2002-03-01 |
2007-06-20 |
SmithKline Beecham Corporation |
Diamino-pyrimidines and their use as angiogenesis inhibitors
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
AU2003231231A1
(en)
|
2002-05-06 |
2003-11-11 |
Bayer Pharmaceuticals Corporation |
Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders
|
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
WO2004005418A2
(en)
|
2002-07-02 |
2004-01-15 |
Kimberly-Clark Worldwide, Inc. |
Elastomeric adhesive compositions and laminates
|
|
CA2491895C
(en)
|
2002-07-09 |
2011-01-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
|
BR0313059B8
(pt)
|
2002-07-29 |
2021-07-27 |
Rigel Pharmaceuticals |
composto, e, composição farmacêutica
|
|
ATE375342T1
(de)
|
2002-08-02 |
2007-10-15 |
Ab Science |
2-(3-aminoaryl)amino-4-aryl-thiazole und ihre verwendung als c-kit inhibitoren
|
|
PL375447A1
(en)
|
2002-08-14 |
2005-11-28 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
|
DE10240261A1
(de)
|
2002-08-31 |
2004-03-11 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Halogen-Metall-Austauschreaktionen
|
|
DE10240262A1
(de)
|
2002-08-31 |
2004-03-11 |
Clariant Gmbh |
Verfahren zur metallorganischen Herstellung organischer Zwischenprodukte über Aryllithium-Basen
|
|
US20050282814A1
(en)
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
AU2003282726B2
(en)
|
2002-10-03 |
2010-10-07 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
US20060167021A1
(en)
|
2002-10-04 |
2006-07-27 |
Caritas St. Elizabeth's Medical Center Of Boston, Inc. |
Inhibition of src for treatment of reperfusion injury related to revascularization
|
|
EP1553947A4
(en)
|
2002-10-21 |
2006-11-29 |
Bristol Myers Squibb Co |
QUINAZOLINONES AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
|
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
DE10250708A1
(de)
|
2002-10-31 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
WO2004041814A1
(en)
|
2002-11-04 |
2004-05-21 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl-pyramidine derivatives as jak inhibitors
|
|
US20050101576A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Novacea, Inc. |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
|
|
US8034831B2
(en)
|
2002-11-06 |
2011-10-11 |
Celgene Corporation |
Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
|
|
BR0316386A
(pt)
|
2002-12-06 |
2005-09-27 |
Warner Lambert Co |
Benzoxazin-3-onas e seus derivados como inibidores de p13k
|
|
JP3837670B2
(ja)
|
2002-12-12 |
2006-10-25 |
富士通株式会社 |
データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
|
|
MXPA05006727A
(es)
|
2002-12-20 |
2005-09-08 |
Pharmacia Corp |
Acidos heteroarilalcanoicos como antagonistas de receptor de integrina.
|
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
CA2510050A1
(en)
|
2002-12-20 |
2004-07-22 |
Pharmacia Corporation |
The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
|
|
DE60324461D1
(de)
|
2002-12-24 |
2008-12-11 |
Astrazeneca Ab |
Therapeutische quinazolin-derivate
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
AP2065A
(en)
|
2003-02-07 |
2009-11-26 |
Janssen Pharmaceutica Nv |
Pyrimidine derivatives for the prevention of HIV infection
|
|
US7585861B2
(en)
|
2003-02-07 |
2009-09-08 |
Janssen Pharmaceutica, N.V. |
HIV inhibiting 1,2,4-triazines
|
|
CA2515544A1
(en)
|
2003-02-11 |
2004-08-26 |
Kemia Inc. |
Compounds for the treatment of viral infection
|
|
CL2004000306A1
(es)
|
2003-02-20 |
2005-04-08 |
Tibotec Pharm Ltd |
Compuestos derivados de pirimidina sustituidas con indano; proceso para su preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; y su uso para el tratamiento o profilaxis de una enfermedad infecciosa.
|
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
|
CA2559670A1
(en)
|
2003-04-14 |
2004-10-28 |
Gabor Pragai |
Stable amlodipine maleate formulations
|
|
US20040265375A1
(en)
|
2003-04-16 |
2004-12-30 |
Platteeuw Johannes J. |
Orally disintegrating tablets
|
|
JP5047613B2
(ja)
|
2003-04-24 |
2012-10-10 |
クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ |
ヒドロゲルコンタクトレンズ及び包装システム及びそれらの製造方法
|
|
PT1656372E
(pt)
|
2003-07-30 |
2013-06-27 |
Rigel Pharmaceuticals Inc |
Métodos para o tratamento ou prevenção de doenças autoimunes com compostos de 2,4-pirimidinadiamina
|
|
SI2287156T1
(sl)
|
2003-08-15 |
2013-09-30 |
Novartis Ag |
2,4-di(fenilamino)-pirimidini, uporabni pri zdravljenju neoplastičnih bolezni, vnetnih motenj in motenj imunskega sistema
|
|
GB0321710D0
(en)
|
2003-09-16 |
2003-10-15 |
Novartis Ag |
Organic compounds
|
|
CN100584832C
(zh)
|
2003-09-18 |
2010-01-27 |
诺瓦提斯公司 |
可用于治疗增殖性病症的2,4-二(苯基氨基)嘧啶类
|
|
AU2005231507B2
(en)
|
2004-04-08 |
2012-03-01 |
Targegen, Inc. |
Benzotriazine inhibitors of kinases
|
|
JP5275628B2
(ja)
|
2004-08-25 |
2013-08-28 |
ターゲジェン インコーポレーティッド |
複素環式化合物および使用方法
|
|
US7210697B2
(en)
|
2004-12-16 |
2007-05-01 |
Tricam International, Inc. |
Convertible handle
|
|
EP1841760B1
(en)
|
2004-12-30 |
2011-08-10 |
Exelixis, Inc. |
Pyrimidine derivatives as kinase modulators and method of use
|
|
GT200600008A
(es)
*
|
2005-01-18 |
2006-08-09 |
|
Formulacion de compresion directa y proceso
|
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
AU2006227628A1
(en)
|
2005-03-16 |
2006-09-28 |
Targegen, Inc. |
Pyrimidine compounds and methods of use
|
|
US20070032493A1
(en)
|
2005-05-26 |
2007-02-08 |
Synta Pharmaceuticals Corp. |
Method for treating B cell regulated autoimmune disorders
|
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
|
CN105348203B
(zh)
|
2005-06-08 |
2018-09-18 |
里格尔药品股份有限公司 |
抑制jak途径的组合物和方法
|
|
AU2006254825A1
(en)
|
2005-06-08 |
2006-12-14 |
Targegen, Inc. |
Methods and compositions for the treatment of ocular disorders
|
|
WO2006137658A1
(en)
|
2005-06-20 |
2006-12-28 |
Dongbu Hitek Co., Ltd. |
New substituted 1,3-thiazole derivatives or pharmaceutically acceptable salts thereof having immunosuppression and inflammation inhibitory acitivity, intermediate compounds or pharmaceutically acceptable salts thereof, a process for the preparation thereof, and pharmaceutical composition comprising the same
|
|
BRPI0612594A2
(pt)
*
|
2005-06-29 |
2010-11-23 |
Panacea Biotec Ltd |
composições farmacêuticas de liberação modificada e processo de pereparação das mesmas
|
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
EP2270014A1
(en)
|
2005-09-22 |
2011-01-05 |
Incyte Corporation |
Azepine inhibitors of janus kinases
|
|
US20070072682A1
(en)
|
2005-09-29 |
2007-03-29 |
Crawford James T Iii |
Head to head electronic poker game assembly and method of operation
|
|
JP5191391B2
(ja)
*
|
2005-11-01 |
2013-05-08 |
ターゲジェン インコーポレーティッド |
キナーゼのビ−アリールメタ−ピリミジン阻害剤
|
|
UA109411C2
(uk)
*
|
2005-11-01 |
2015-08-25 |
|
N-трет-бутил-3-(2-хлор-5-метилпіримідин-4-іламіно)бензолсульфонамід та його застосування в способі одержання сполуки
|
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
US20070161645A1
(en)
|
2005-11-02 |
2007-07-12 |
Targegen, Inc. |
Thiazole inhibitors targeting resistant kinase mutations
|
|
EP1948647A1
(en)
|
2005-11-03 |
2008-07-30 |
SGX Pharmaceuticals, Inc. |
Pyrimidinyl-thiophene kinase modulators
|
|
US8772346B2
(en)
|
2005-11-09 |
2014-07-08 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition
|
|
US8143255B2
(en)
|
2005-11-16 |
2012-03-27 |
S*Bio Pte Ltd. |
Heteroalkyl linked pyrimidine derivatives
|
|
UA116187C2
(uk)
|
2005-12-13 |
2018-02-26 |
Інсайт Холдінгс Корпорейшн |
ГЕТЕРОАРИЛЗАМІЩЕНІ ПІРОЛО[2,3-b]ПІРИДИНИ Й ПІРОЛО[2,3-b]ПІРИМІДИНИ ЯК ІНГІБІТОРИ ЯНУС-КІНАЗИ
|
|
CA2640398A1
(en)
*
|
2006-01-30 |
2007-08-09 |
Exelixis, Inc. |
4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
|
|
WO2007098507A2
(en)
|
2006-02-24 |
2007-08-30 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
|
MX349787B
(es)
*
|
2006-04-04 |
2017-08-11 |
Kg Acquisition Llc |
Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
|
|
US7691858B2
(en)
|
2006-04-25 |
2010-04-06 |
Targegen, Inc. |
Kinase inhibitors and methods of use thereof
|
|
CA2652300A1
(en)
*
|
2006-05-15 |
2007-11-22 |
Acadia Pharmaceuticals Inc. |
Pharmaceutical formulations of pimavanserin
|
|
US8030487B2
(en)
|
2006-07-07 |
2011-10-04 |
Targegen, Inc. |
2-amino—5-substituted pyrimidine inhibitors
|
|
JP2009544592A
(ja)
|
2006-07-21 |
2009-12-17 |
ノバルティス アクチエンゲゼルシャフト |
Ｊａｋキナーゼ阻害剤としての２，４−ジ（アリールアミノ）−ピリミジン−５−カルボキサミド化合物
|
|
US20080021013A1
(en)
|
2006-07-21 |
2008-01-24 |
Cephalon, Inc. |
JAK inhibitors for treatment of myeloproliferative disorders
|
|
WO2008057233A2
(en)
*
|
2006-10-25 |
2008-05-15 |
The Regents Of The University Of California |
Models of erythropoiesis
|
|
WO2008157208A2
(en)
|
2007-06-13 |
2008-12-24 |
Incyte Corporation |
Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
DE102007034947B4
(de)
*
|
2007-07-26 |
2009-06-18 |
Siemens Ag |
Vorrichtung zum Entladen eines Stapels von auf ihren Schmalseiten stehenden flachen Gegenständen
|
|
EP2179037A4
(en)
*
|
2007-08-21 |
2010-12-22 |
Nodality Inc |
DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES
|
|
WO2009046416A1
(en)
|
2007-10-05 |
2009-04-09 |
Targegen Inc. |
Anilinopyrimidines as jak kinase inhibitors
|
|
US20100310563A1
(en)
*
|
2007-11-30 |
2010-12-09 |
Bumm Thomas G P |
Methods for treating induced cellular proliferative disorders
|
|
RU2493828C2
(ru)
*
|
2008-07-14 |
2013-09-27 |
Отономи, Инк. |
Модулирующие апоптоз композиции с контролируемым высвобождением и способы лечения заболеваний уха
|
|
WO2010017122A2
(en)
|
2008-08-05 |
2010-02-11 |
Targegen Inc. |
Methods of treating thalassemia
|
|
US8987243B2
(en)
|
2008-12-11 |
2015-03-24 |
Cti Biopharma Corp. |
11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-maleate salt
|
|
EP2229938B9
(en)
|
2009-03-13 |
2012-04-25 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Ezetimibe compositions
|
|
US20100297194A1
(en)
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
|
US20100278921A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Fischer Cristina M |
Solid oral formulation of abt-263
|
|
US20120190806A1
(en)
|
2009-07-31 |
2012-07-26 |
Basf Se |
Phosphine Borane Compounds Comprising Imidazol Groups And Method For Producing Phosphine Borane Compounds Comprising Imidazol Groups
|
|
US20120157500A1
(en)
|
2009-08-24 |
2012-06-21 |
Weikang Tao |
Jak inhibition blocks rna interference associated toxicities
|
|
AU2010363329A1
(en)
*
|
2010-11-07 |
2013-05-09 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
AR087276A1
(es)
|
2011-07-21 |
2014-03-12 |
Sanofi Sa |
Composiciones y metodos para tratar policitemia vera y trombocitemia esencial
|
|
WO2013059548A1
(en)
|
2011-10-19 |
2013-04-25 |
Sanofi |
Compositions and methods for treating cancer using jak2 inhibitor
|